163 related articles for article (PubMed ID: 70292)
21. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
[TBL] [Abstract][Full Text] [Related]
22. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
Takaki K; Harada M; Sairenji T; Hinuma Y
J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
de-Thé G
IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
[TBL] [Abstract][Full Text] [Related]
24. [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].
De la Barrera S; Fejes M; Riera NE; Scaglione C; Pérez Blanco R; de Bracco MM
Rev Argent Microbiol; 1985; 17(3):137-43. PubMed ID: 2829276
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
[TBL] [Abstract][Full Text] [Related]
26. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
Aya T
Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies in three populations of Burkitt's lymphoma patients.
Vainio E; Lenoir GM; Franklin RM
Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
[TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC).
Jilg W; Bogedain C; Mairhofer H; Gu SY; Wolf H
Virology; 1994 Aug; 202(2):974-7. PubMed ID: 8030258
[TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
[TBL] [Abstract][Full Text] [Related]
30. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).
Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E
Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438
[TBL] [Abstract][Full Text] [Related]
31. Etiology of endemic Burkitt's lymphoma.
Olweny CL
IARC Sci Publ; 1984; (63):647-53. PubMed ID: 6100285
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Magrath I; Henle W; Owor R; Olweny C
N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
[No Abstract] [Full Text] [Related]
33. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
34. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
Pearson G; Klein G; Henle G; Henle W; Clifford P
J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
[TBL] [Abstract][Full Text] [Related]
35. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
Magrath IT; Henle W
IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
[No Abstract] [Full Text] [Related]
36. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R
J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787
[TBL] [Abstract][Full Text] [Related]
37. Association of Epstein-Barr virus and American Burkitt's lymphoma.
Easton JM; Ablashi DV; Levine PH; Armstrong GR
IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
[No Abstract] [Full Text] [Related]
38. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
Pearson GR; Orr TW
J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
Gunvén P; Klein G; Henle G; Henle W; Clifford P
Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
[No Abstract] [Full Text] [Related]
40. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
Khyatti M; Stefanescu I; Blagdon M; Menezes J
J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
